Controversial drug trial for welfare recipients to be postponed

By Stephanie Peatling
Updated November 23 2017 - 8:08am, first published 8:04am
Dr Michael Gannon, President of the Australian Medical Association (AMA), addresses the National Press Club of Australia in Canberra on Wednesday 23 August 2017. fedpol Photo: Alex Ellinghausen
Dr Michael Gannon, President of the Australian Medical Association (AMA), addresses the National Press Club of Australia in Canberra on Wednesday 23 August 2017. fedpol Photo: Alex Ellinghausen

A controversial trial of drug testing welfare recipients will almost certainly be postponed after the Turnbull government conceded it was unlikely to win sufficient support from the Senate crossbench.